Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets Average (2020 - 2023)

Historic Assets Average for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to $487.1 million.

  • ADC Therapeutics' Assets Average fell 741.48% to $487.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $487.1 million, marking a year-over-year decrease of 741.48%. This contributed to the annual value of $491.1 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that ADC Therapeutics reported Assets Average of $487.1 million as of Q3 2023, which was down 741.48% from $487.5 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Assets Average high stood at $564.7 million for Q4 2021, and its period low was $447684.0 during Q3 2020.
  • For the 4-year period, ADC Therapeutics' Assets Average averaged around $449.1 million, with its median value being $499.4 million (2022).
  • As far as peak fluctuations go, ADC Therapeutics' Assets Average surged by 12301865.07% in 2021, and later tumbled by 1155.49% in 2023.
  • Quarter analysis of 4 years shows ADC Therapeutics' Assets Average stood at $447684.0 in 2020, then skyrocketed by 126039.16% to $564.7 million in 2021, then dropped by 9.46% to $511.3 million in 2022, then fell by 4.73% to $487.1 million in 2023.
  • Its Assets Average stands at $487.1 million for Q3 2023, versus $487.5 million for Q2 2023 and $479.3 million for Q1 2023.